Adoption of high technology medical imaging and hospital quality and efficiency: Towards a conceptual framework

The International Journal of Health Planning and Management
Guillermo A SandovalGeoffrey M Anderson

Abstract

Measuring the value of medical imaging is challenging, in part, due to the lack of conceptual frameworks underlying potential mechanisms where value may be assessed. To address this gap, this article proposes a framework that builds on the large body of literature on quality of hospital care and the classic structure-process-outcome paradigm. The framework was also informed by the literature on adoption of technological innovations and introduces 2 distinct though related aspects of imaging technology not previously addressed specifically in the literature on quality of hospital care: adoption (a structural hospital characteristic) and use (an attribute of the process of care). The framework hypothesizes a 2-part causality where adoption is proposed to be a central, linking factor between hospital structural characteristics, market factors, and hospital outcomes (ie, quality and efficiency). The first part indicates that hospital structural characteristics and market factors influence or facilitate the adoption of high technology medical imaging within an institution. The presence of this technology, in turn, is hypothesized to improve the ability of the hospital to deliver high quality and efficient care. The second part descr...Continue Reading

References

May 26, 1978·Science·A Donabedian
Jun 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·C Pritchard
Apr 1, 1991·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D G Fryback, J R Thornbury
Sep 11, 1991·Medical Care·S T FlemingR T Wroblewski
Dec 21, 1989·The New England Journal of Medicine·A J HartzA A Rimm
Sep 1, 1987·American Journal of Public Health·R W DuboisW H Rogers
Mar 1, 1988·Medical Care·S L White, T N Chirikos
Jan 1, 1986·Social Science & Medicine·F A Sloan, J Valvona
Jul 26, 1995·JAMA : the Journal of the American Medical Association·J H SilberS V Williams
Oct 1, 1994·Medical Care·A M FendrickJ S Schwartz
Jan 1, 1993·Health Affairs·S Q Duffy, B Friedman
Apr 1, 1993·The Journal of Nursing Administration·L R Lutjens
Jan 1, 1996·International Journal of Technology Assessment in Health Care·P RissanenP Paavolainen
Nov 21, 1997·Medical Care·L H AikenE T Lake
Nov 21, 1997·Medical Care·P H Mitchell, S M Shortell
Jan 1, 1992·Journal of Clinical Engineering·F G Hawkins
Apr 14, 1999·The Journal of Nursing Administration·G van Servellen, M A Schultz
Mar 11, 1984·Journal of Health Economics·A A RomeoR H Lee
Feb 9, 1986·Journal of Health Economics·F A SloanK W Adamache
Jun 4, 1999·BMJ : British Medical Journal·B JarmanL I Iezzoni
Jan 5, 2000·Journal of Nursing Care Quality·M E Murphy, C M Noetscher
Sep 9, 2000·JAMA : the Journal of the American Medical Association·J J AllisonR M Centor
Jan 5, 2001·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·F A MettlerC A Kelsey
Feb 24, 2001·Journal of Health Economics·V Ho, B H Hamilton
Jun 26, 2001·European Journal of Public Health·A Clarke, R Rosen
Jan 5, 2002·Journal of Health Politics, Policy and Law·J Needleman
Jan 5, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·J Mant
May 31, 2002·The New England Journal of Medicine·Jack NeedlemanKatya Zelevinsky
Jun 8, 2002·BMC Health Services Research·Dana B MukamelAnil Bamezai
Jun 20, 2002·Journal of Substance Abuse Treatment·Paul M Roman, J Aaron Johnson
Aug 1, 2002·The Medical Journal of Australia·Rohan J H Hammett, Roger D Harris

❮ Previous
Next ❯

Citations

May 28, 2019·Journal of Health Organization and Management·Guillermo A SandovalGeoffrey M Anderson
Nov 9, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Marie DregerCornelia Henschke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.